FairJourney Biologics is an established company with an outstanding track record of biotech and biopharmaceutical partners, which offers a range of assets and services on antibody engineering, discovery and production.
Our naïve and immune libraries from humans, rodents and llama together with our know-how with immunization and panning protocols allow us to contribute to the pipeline of our partners on complex targets.
FairJourney Biologics and IONTAS combined capabilities in 2020 as a fee for service antibody discovery company. The combined operations allow a complete offering around antibody discovery. Using fully validated naïve libraries with parallel immune approaches and the unrivalled mammalian display technology to optimise antibody discovery research. The team of more than 100 scientists, anchored in a high-profile network of advisors, has successfully completed more than 150 projects, with over 50 biotechnology and pharmaceutical companies.
Our naïve and immune libraries from humans, rodents and llama together with our know-how with immunization and panning protocols allow us to contribute to the pipeline of our partners on complex targets.
FairJourney Biologics and IONTAS combined capabilities in 2020 as a fee for service antibody discovery company. The combined operations allow a complete offering around antibody discovery. Using fully validated naïve libraries with parallel immune approaches and the unrivalled mammalian display technology to optimise antibody discovery research. The team of more than 100 scientists, anchored in a high-profile network of advisors, has successfully completed more than 150 projects, with over 50 biotechnology and pharmaceutical companies.
Location: Portugal, Porto
Employees: 51-200
Founded date: 2012
Investors 1
| Date | Name | Website |
| - | GHO Capita... | ghocapital... |
Mentions in press and media 4
| Date | Title | Description |
| 17.09.2021 | FairJourney Biologics announces THE ANTIBODY SERIES 2022 | FairJourney Biologics announces THE ANTIBODY SERIES 2022 17-09-2021 Porto, Portugal –FairJourney Biologics SA, leader in the discovery and optimisation of antibodies, today announced, after the overwhelming success of the 2021 ANTIBODY SERI... |
| 01.09.2021 | FairJourney Biologics expands into new facilities in Porto, Portugal | FairJourney Biologics expands into new facilities in Porto, Portugal 01-09-2021 FairJourney Biologics SA (FJB), leader in the discovery and optimisation of antibodies, announced it has relocated into a larger, newly purpose-built research c... |
| 01.07.2021 | FairJourney Biologics introduces 'THE ANTIBODY SERIES' Conference | FairJourney Biologics introduces 'THE ANTIBODY SERIES' Conference 01-07-2021 FairJourney Biologics SA (FJB), leaders in the discovery and optimization of antibodies, today announced the launch of the “THE ANTIBODY SERIES” - a one-day confer... |
| 12.04.2021 | FairJourney Biologics enters next-generation antibody discovery collaboration with argenx | FairJourney Biologics enters next-generation antibody discovery collaboration with argenx 12-04-2021 Porto, Portugal, and Cambridge and London, UK: FairJourney Biologics S.A (FJB) and IONTAS Limited (IONTAS), leaders in the discovery and op... |